o-Toluoyl Chloride CAS 933-88-0 Tolvaptan Intermediate Factory Zoo
Chaw tsim khoom, siab zoo, kev lag luam ntau lawm
Tolvaptan thiab lwm tus neeg nruab nrab:
Tolvaptan CAS 150683-30-0
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3
o-Toluoyl Chloride CAS 933-88-0
Tom ntej: 4-Amino-2-Methylbenzoic Acid CAS 2486-75-1
Tom ntej: 2-Methyl-4-Nitrobenzoic Acid CAS 1975-51-5
Tshuaj npe | o-Toluoyl Chloride |
Synonyms | 2-Methylbenzoyl Chloride |
CAS Nr | 933-88-0 : kuv |
CAT Number | Qauv Zauv: RF-PI396 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C8H7CLO |
Molecular Luj | 154.59 Nws |
Melting Point | 159.5-160.9 ℃ |
Boiling Point | 88.0 ~ 90.0 ℃ / 12 mmHg (lit.) |
Qhov ntom | 1.185 g / mL ntawm 25 ℃ (lit.) |
Refractive Index | n20/D 1.5549 (lit.) |
Dej Solubility | Reacts nrog dej |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Colorless Clear kua |
Assay | ≥99.0% |
Benzoyl Chloride | ≤ 0.30% |
M&P-Methyl Benzoyl Chloride | ≤0.50% |
O-Toluic acid | ≤0.50% |
Lwm yam kev tsis pom zoo | ≤ 0.20% |
Tag nrho cov impurities | ≤ 1.0% |
Poob rau ziab | ≤0.50% |
Test Standard | Enterprise Standard |
Kev siv | Pharmaceutical Intermediates |
Pob: Lub raj mis, 25kg / chim lossis 180kg Yas nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.
o-Toluoyl Chloride (CAS 933-88-0) yog siv los ua tshuaj nruab nrab.o-Toluoyl Chloride yog siv nyob rau hauv lub synthesis yog quinolinone compounds li SARS CoV 3CLpro inhibitors.Kuj tseem siv rau hauv kev sib txuas ntawm benzooxaboroles ua cov tshuaj tiv thaiv kab mob hauv qhov ncauj.o-Toluoyl Chloride yog qhov nruab nrab ntawm Tolvaptan (CAS 150683-30-0) rau kev kho mob hyponatremia.Tolvaptan, tseem hu ua OPC-41061, yog ib qho kev xaiv, kev sib tw arginine vasopressin receptor 2 antagonist siv los kho hyponatremia (cov ntshav sodium tsawg) cuam tshuam nrog kev mob plawv tsis ua haujlwm, cirrhosis, thiab cov tsos mob ntawm cov tshuaj tiv thaiv tsis tsim nyog (SIADH).Otsuka Pharmaceutical muaj ntawv tso cai tolvaptan nyob rau hauv lub npe lag luam Samsca tom qab FDA pom zoo cov tshuaj nyob rau lub Tsib Hlis 2009.